Data shown is for informational purposes only and does not constitute investment advice. TopFund is not SEBI-registered. Consult a SEBI-registered advisor before investing.
Shri Ahimsa Naturals IPO
Price Band
₹113.0–119.0
Issue Size
₹73.81 Cr
Lot Size
1,200 shares
Min Investment
₹142,800
GMP
+₹19.5 (16.39%)
Issue Price
₹119.0
Subject to Sauda
₹17800
Paid only if allotted
Shri Ahimsa Naturals IPO AI Summary
- Shri Ahimsa Naturals IPO is listed on NSE SME.
- Price band: ₹113.0–₹119.0 per share, lot size 1,200 shares (min. investment ₹142,800).
- Subscription window: 25 Mar–27 Mar 2025, listing on 02 Apr 2025.
- Current GMP is +₹19.5 (16.39%), an estimated listing price of ₹139 — unofficial and can change daily.
TopFund is not SEBI-registered — this is educational analysis, not personalized investment advice.
Shri Ahimsa Naturals IPO — Third-Party Research Views
Reviews below reflect analyst calls made before this IPO closed on 27 Mar 2025 — not a current signal.
Recommendations are sourced from third-party research firms and are not TopFund's own investment advice.
Important Dates
Subscription Status
Subscription data unavailable
Shri Ahimsa Naturals IPO Grey Market Premium (GMP) Today
GMP
+₹19.5
GMP %
+16.39%
Est. Listing
₹138.5
Updated: 25 Jul 2026 14:30
About the Company
Incorporated in 1990, Shri Ahimsa Naturals Limited extracts and manufactures Caffeine Anhydrous, Green Coffee Bean Extracts, and Crude Caffeine, also trading other herbal extracts. The company's products find its application in the food & beverage, nutraceuticals, cosmetics and pharmaceutical industries due to their health benefits. The company's product portfolio includes the following:- Natural Caffeine:Extracted from seeds of various plants like coffee and tea, their caffeine is used in energy drinks, soft drinks, cosmetics, and pharmaceuticals. Green Coffee Bean Extract:Sourced from unroasted green coffee seeds, this extract is rich in chlorogenic acid, known for its antioxidant properties and potential weight loss benefits. The company exports its products to the USA, Germany, South Korea, the UK, Thailand, etc. For the period ending September 30, 2024, revenue from exports (including deemed exports) of the Company’s products was ₹3,530.91 lakhs, ₹7,463.71 lakhs, and ₹9,988.01 lakhs for Fiscal 2023 and ₹5,633.50 lakhs for Fiscal 2022. The manufacturing unit is situated in Jaipur, Rajasthan. The manufacturing facility complies with 2015 [Quality Management System], 2018 ISO 22000 [Food Safety Management System], 2018 ISO 45001 [Occupational Health & Safety Management System], 2015 ISO 14001 [Environmental Management System], HACCP, and GMP guidelines for superior quality. As of March 2025, the company employed about 80 employees. Competitive Strength: Experienced Promoters and Management Team. Manufacturing facility supported by technology-driven process and R&D capabilities. Long term relationship with the clients.
Company Financials (₹ Cr)
As of 2024-09-30
| Period Ended | 30 Sep 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
|---|---|---|---|---|
| Assets | 111.39 | 103.15 | 74.13 | 40.34 |
| Total Income | 41.37 | 78.70 | 106.14 | 58.94 |
| Profit After Tax | 9.74 | 18.67 | 38.21 | 11.02 |
| NET Worth | 99.67 | 83.89 | 65.22 | 27.02 |
| Reserves and Surplus | 80.54 | 65.57 | 59.99 | 21.78 |
| Total Borrowing | 4.85 | 13.83 | 3.43 | 6.36 |
Key Ratios
EPS
₹9.76
NAV
₹45.79
ROE
22.25%
ROCE
25.69%
RoNW
22.25%
P/B Value
2.60
P/E Ratio
12.19
Market Cap
₹277.63 Cr
PAT Margin
23.91%
Debt/Equity
0.07
Promoters
Nemi Chand Jain, Sumitra Jain, Amit Kumar Jain, Sumit Jain, Prerna Jain, Ahimsa Holdings Pvt.Ltd. and Bimneer Investments Pvt.Ltd.
Objects of the Issue
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects: # Issue Objects Est Amt (₹ Cr.) 1 Investment in Wholly-Owned Subsidiary, Shri Ahimsa Healthcare Pvt.Ltd. (SAHPL) for setting up a manufacturing unit at Sawarda, Jaipur, Rajasthan 35.00 2 General Corporate Purposes 4.30 3 Issue Expenses 10.71 Total 50.00
IPO Evaluation
Generated 23 Sep 2026Revenue Trend
Revenue was ₹58.94 Cr in the fiscal year ending March 31, 2022, rising to ₹106.14 Cr by March 31, 2023. However, it declined to ₹78.70 Cr for the fiscal year ending March 31, 2024, and further decreased to ₹41.37 Cr by September 30, 2024, though this is a 9-month figure, not a full year, so isn't directly comparable.
Profit Trend
Profit After Tax (PAT) was ₹11.02 Cr in the fiscal year ending March 31, 2022, increasing to ₹38.21 Cr by March 31, 2023. It then fell to ₹18.67 Cr for the fiscal year ending March 31, 2024, and further decreased to ₹9.74 Cr by September 30, 2024, though this is a 9-month figure, not a full year, so isn't directly comparable.
Grey Market Premium, Explained
The Grey Market Premium (GMP) indicates the expected listing price of an IPO based on unofficial trading before its official listing. A higher GMP suggests strong demand, while a lower GMP may indicate weaker interest.
Who This IPO Suits
Investors comfortable with short-term volatility and a long-term horizon typically weigh IPOs like this against their investment goals and risk tolerance. It's essential to consider the company's financial health and market conditions before making a decision.
Who May Want to Wait
Investors who are risk-averse or those who prefer stable and established companies may want to avoid IPOs like this, which can involve higher volatility and uncertainty.
IPO Timeline, Explained
The IPO process includes several key dates: the opening date for subscription is March 25, 2025, the closing date is March 27, 2025, the allotment date is March 28, 2025, and the listing date is April 2, 2025.
Listing Gains — The Risk
Listing gains refer to the potential profit an investor can make by selling shares on the listing day. However, these gains are not guaranteed and can be influenced by market conditions, demand for the stock, and overall investor sentiment.
This evaluation is generated from Shri Ahimsa Naturals's own public IPO filing data for educational purposes and is not investment advice or a recommendation to apply, subscribe to, or avoid this issue — see Broker Recommendations below for named third-party research views (clearly attributed, not TopFund's own). TopFund is not a SEBI-registered investment adviser — see our Disclaimer.
Frequently Asked Questions
What is Shri Ahimsa Naturals IPO GMP today?
Shri Ahimsa Naturals IPO GMP today is +₹19.5 (16.39%), indicating an estimated listing price of ₹139. GMP is an unofficial grey-market indicator and can change daily.
What is the price band of Shri Ahimsa Naturals IPO?
The price band of Shri Ahimsa Naturals IPO is ₹113.0–₹119.0 per share.
When does Shri Ahimsa Naturals IPO open and close?
Shri Ahimsa Naturals IPO opens on 25 March 2025 and closes on 27 March 2025.
When does Shri Ahimsa Naturals IPO list on the stock exchange?
Shri Ahimsa Naturals IPO listed on 02 April 2025 at ₹138.5.
What is the lot size for Shri Ahimsa Naturals IPO?
The lot size for Shri Ahimsa Naturals IPO is 1200 shares, requiring a minimum investment of ₹142,800.
What is the lot size for this IPO?
The lot size for this IPO is 1200 shares.
What is the minimum investment required?
The minimum investment required is ₹142,800.
What is the price band for the IPO?
The price band for the IPO is ₹113.0 to ₹119.0.
When does the IPO open and close for subscription?
The IPO opens on March 25, 2025, and closes on March 27, 2025.
What does GMP mean?
GMP stands for Grey Market Premium, which indicates the expected listing price of the IPO based on unofficial trading.
Issue Details
Investor Allocation
Registrar
Lead Managers / Book Running
IPO Timeline
Open
25 Mar 2025
Close
27 Mar 2025
Allotment
28 Mar 2025
Listing
02 Apr 2025
Similar IPOs
Plan Your IPO Investment
Related Articles
Community Sentiment
What are other investors planning for Shri Ahimsa Naturals?
No votes yet — be the first to share your view.
Sign in to voteDiscussion
User-generated content — not investment advice, and not verified or endorsed by TopFund.
No comments yet — start the discussion.